Newsroom

May 31, 2022 By Sean Whooley After years of running a hospitalist group and mentoring hospitals on quality improvement, blood clot prevention and more, Dr. Jordan Messler found himself falling into a lot of work on diabetes. Messler cut his teeth on quality improvement around diabetes, observing that inpatient glycemia impacts about 40%-50% of patients in the hospital. That work brought him to...

Strategic Partnerships, Product Innovation and Customer Expansion Underpin Insulin Dosing Technology Company’s Sustained Growth WALTHAM, Mass. (March 15, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced that it has significantly expanded the deployment of its eGlycemic Management System® (eGMS) over the past 12 months to...

JANUARY 12, 2022 This digital health collaboration combines Roche’s expertise in medical devices and IT solutions with Glytec’s FDA-cleared insulin dosing decision support software, Glucommander, to address the challenges with inpatient blood sugar management at the hospital bedside. Glucommander will be the first software application available to run on Roche’s smart-device next-generation...

JANUARY 12, 2022 by SEAN WHOOLEY Glytec announced today that it entered into a strategic partnership with Roche Diagnostics USA for a digital health collaboration. Waltham, Massachusetts-based Glytec’s partnership combines its FDA-cleared Glucommander insulin dosing decision support software with Roche’s expertise in medical devices and IT solutions in an effort to address the challenges...

JANUARY 12, 2022 by Conor Hale Roche has launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its own apps. The cobas pulse will start shipping to select countries in Europe, carrying a CE mark, Roche said during the J.P. Morgan Healthcare Conference. The company said it plans to seek...

JANUARY 12, 2022 Amanda Petersen The partnership will leverage Glytec's insulin dosing support software to address challenges with hospital inpatient blood sugar management. Glytec, a Gold winner in the 2021 Medical Design Excellence Awards competition, has nabbed a rather big partnership with Roche that will ultimately benefit countless hospital patients and their clinicians. Through a digital...

February 2022 Glytec and Roche Diagnostics USA last month announced a digital health collaboration that combines Roche’s expertise in medical devices and IT solutions with Glytec’s FDA-cleared insulin dosing decision support software, Glucommander™, to address the pervasive challenges with inpatient blood sugar management at the hospital bedside. Glucommander will be the first software...

JANUARY 6, 2022 Karen Berger, PharmD Type 1 diabetes requires patients to have knowledge and skill to manage medication and potential complications. Type 1 diabetes (T1D) is caused when the immune system destroys the insulin-producing β cells of the pancreas. T1D accounts for up to 10% of all cases of diabetes. Because new-onset T1D can occur in any age group and people with the disease live for...

Leader in Endocrinology Research Implements eGlycemic Management System Across Hospitals, Dedicates Resources Towards Research and Development WALTHAM, Mass. (January 25, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a new strategic partnership with Nebraska Medicine to advance patient safety and innovation around...

JANUARY 4, 2021 By: Sean Whooley Glytec announced today that its eGlycemic Management System received certified status for information security from HITRUST. Waltham, Massachusetts-based Glytec’s certification validates its platform’s ability to meet the highest standards for protecting sensitive data and information when working with its health system customers. According to a news release,...